Rhein and hesperidin nanoparticles remodel tumor immune microenvironment by reducing CAFs and CCL2 secreted by CAAs for efficient triple-negative breast cancer therapy.

MLA

Huang, Jingyi, et al. “Rhein and Hesperidin Nanoparticles Remodel Tumor Immune Microenvironment by Reducing CAFs and CCL2 Secreted by CAAs for Efficient Triple-Negative Breast Cancer Therapy.” International Immunopharmacology, vol. 141, Nov. 2024, p. 113001. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.113001.

APA

Huang, J., Zhang, H., Ma, L., Ma, N., Luo, N., Jin, W., Shi, J., Xu, S., & Xiong, Y. (2024). Rhein and hesperidin nanoparticles remodel tumor immune microenvironment by reducing CAFs and CCL2 secreted by CAAs for efficient triple-negative breast cancer therapy. International Immunopharmacology, 141, 113001. https://doi.org/10.1016/j.intimp.2024.113001

Chicago

Huang, Jingyi, Hongyan Zhang, Lisha Ma, Ninghui Ma, Ningchao Luo, Wanyu Jin, Jingbin Shi, Shujun Xu, and Yang Xiong. 2024. “Rhein and Hesperidin Nanoparticles Remodel Tumor Immune Microenvironment by Reducing CAFs and CCL2 Secreted by CAAs for Efficient Triple-Negative Breast Cancer Therapy.” International Immunopharmacology 141 (November): 113001. doi:10.1016/j.intimp.2024.113001.